|Podcasts|April 20, 2018
Episode 6: The Pharma vs. Biotech Experience
Author(s)Michelle Maskaly, Christen Harm
On episode 6, Michelle and Christen talk to Lara Sullivan, founder and president of SpringWorks Therapeutics, about the differences in working for legacy pharma vs. small biotech start-ups.
Advertisement
On episode 6, Michelle and Christen talk to Lara Sullivan, founder and president of SpringWorks Therapeutics, about the differences in working for legacy pharma vs. small biotech start-ups.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
2
What Kinds of Disruption are GLP-1s Expected to Face
3
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
4
The Evolving Relationship Between FDA and Biotech
5